Revisiting Leishmania GP63 host cell targets reveals a limited spectrum of substrates

Marie-Michèle Guay-Vincent1, Christine Matte1, Anne-Marie Berthiaume1

  • 1Institut national de la recherche scientifique, Centre Armand-Frappier Santé Biotechnologie, Laval, Quebec, Canada.

Plos Pathogens
|October 3, 2022
PubMed

Insights

Leishmania

Area of Science:

  • Parasitology
  • Cell Biology
  • Molecular Biology

Background:

  • Leishmania parasites infect host phagocytic cells.
  • The zinc-dependent metalloprotease GP63 is a key Leishmania virulence factor.
  • GP63 cleaves host cell proteins, complicating substrate identification.

Purpose of the Study:

  • To re-evaluate GP63 substrates by preventing artefactual degradation.
  • To investigate the impact of GP63 inhibition on host cell protein integrity.
  • To clarify the role of GP63 in Leishmania pathogenesis.

Main Methods:

  • Infection of bone marrow-derived macrophages with wild type, Δgp63, and Δgp63+GP63 L. major.
  • Preparation of cell lysates with and without the metalloprotease inhibitor 1,10-phenanthroline.
  • Analysis of ten previously reported GP63 host cell substrates.

Main Results:

  • Inhibiting GP63 activity prevented degradation of PTP-PEST, mTOR, p65RelA, c-Jun, VAMP3, and NLRP3.
  • SHP-1, Synaptotagmin XI, VAMP8, and Syntaxin-5 were confirmed as genuine GP63 substrates.
  • Efficient GP63 inhibition is crucial for accurate host cell lysate preparation.

Conclusions:

  • Accurate identification of GP63 substrates requires effective inhibition during sample processing.
  • The role of GP63 in Leishmania pathogenesis warrants re-evaluation based on these findings.